EdgeLab S.p.A. Logo

EdgeLab S.p.A.

Designs and manufactures marine and underwater solutions, including AUVs and robotics.

ELB | Euronext Growth

Overview

Corporate Details

ISIN(s):
IT0005627762
LEI:
815600DEC35C84FE7546
Country:
Italy
Address:
Via della Ferriera 1, 57037 Portoferraio

Description

EdgeLab S.p.A. is a high-technology company specializing in the design, development, and manufacturing of marine and underwater solutions. Its core offerings include autonomous underwater vehicles (AUVs), underwater robotics, and advanced sensor systems. The company provides these technologies for both civil and defense applications. Originating as a spinoff from scientific research projects, EdgeLab also engages in research and consultancy services in its fields of expertise, which include micro-systems and bio-systems. The firm focuses on advancing underwater exploration and operational capabilities through innovative technological solutions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 18:42
EDGELAB E KSSL SIGLANO UN ACCORDO STRATEGICO PER RAFFORZARE LA COOPERAZIONE IN…
Italian 267.9 KB
2025-10-13 20:01
EDGELAB PARTECIPA ALLA SESTA EDIZIONE DELLA CONFERENCE EQUITY “NEXT GEMS”
Italian 271.6 KB
2025-09-30 20:53
EDGELAB: IL CONSIGLIO DI AMMINISTRAZIONE HA APPROVATO LA RELAZIONE SEMESTRALE …
Italian 522.5 KB
2025-08-07 12:36
ACCORDO COMMERCIALE GOLDEN POWER BFL
Italian 269.2 KB
2025-04-30 16:00
L’ASSEMBLEA DEGLI AZIONISTI DI EDGELAB APPROVA IL BILANCIO 2024
Italian 282.4 KB
2025-04-10 12:57
PUBBLICAZIONE DELL'AVVISO DI CONVOCAZIONE DELL'ASSEMBLEA ORDINARIA
Italian 302.6 KB
2025-02-21 15:08
Training_Soprintendenza del Mare-Regione Sicilia
Italian 256.7 KB
2025-01-28 17:44
IL CONSIGLIO DI AMMINISTRAZIONE DI EDGELAB S.P.A. HA APPROVATO I CRITERI VALUT…
Italian 269.4 KB
2025-01-15 18:48
CALENDARIO EVENTI SOCIETARI 2025
Italian 267.8 KB
2024-12-30 19:39
EDGELAB DEBUTTA CON SUCCESSO SU EGM
Italian 275.5 KB

Automate Your Workflow. Get a real-time feed of all EdgeLab S.p.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EdgeLab S.p.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EdgeLab S.p.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.